Microfluidics systems are a desirable option for assays including biological and chemical assays because of advantages like less sample and reagent usage, shorter analysis times, and simpler automation processes. Additionally, microfluidics devices enable parallel assay execution, which lowers the overall cost of the experiment. These technologies offer enormous potential in the realm of point-of-care diagnostics based on next-generation sequencing. This is because production is cost-effective, and since systems are highly integrated and portable, which causes the Microfluidics Market to expand favourably during the anticipated period.
The demand for Microfluidics Market based on microfluidics technology is rising as drug delivery applications advance. The development of numerous drug delivery systems based on microfluidics, such as micro-needle arrays, inhaler nozzles, transdermal, and micro-pumps, has a significant impact on drug delivery because of its exact and predictable drug release. Due to its painless drug administration and ability to be integrated with multi-functional systems, transdermal microfluidic drug delivery platforms have attracted a lot of interest. Microfluidics-based arrays for controlled and targeted drug delivery have a number of benefits, including accurate drug release at the desired areas for safety and efficacy.
Source Link- https://cmi-latestreportorientedblogs.blogspot.com/2023/01/microfluidics-market-size-share-outlook.html
